- About Us
- Contact Us
Soluble Systems, LLC, markets a line of advanced wound care products under the brand names of TheraSkin® and TheraGauze®.
The Company’s products compete in the U.S. within two large and growing wound care markets, active biologics and synthetic dressings. Both TheraSkin and TheraGauze are designed to help healthcare professionals treat difficult-to-heal chronic wounds where co-morbidities, age, diabetes and other factors are driving the need for clinically and cost effective wound healing.
TheraSkin is a biologically active human skin allograft and represents the company’s initial entrée into the rapidly growing regenerative medical market. TheraSkin jumpstarts healing in non-progressing chronic wounds, including diabetic foot ulcers, venous stasis ulcers, dehisced surgical wounds, and pressure ulcers. TheraSkin is FDA regulated as human cell and tissue product (HCT/P) for homologous use [graft] to repair skin over any wound. Available in two sizes, TheraSkin carries the American Podiatric Medical Association Seal of Approval.
The Company began marketing TheraSkin in late 2009 under an exclusive, long-term Distribution Agreement with the Skin and Wound Allograft Institute (SWAI), a wholly owned subsidiary of LifeNet Health, Inc. (LNH), a non-profit global leader in regenerative medicine and the world’s largest provider of bio-implants and organs for transplantation. SWAI was formed in 2008 to provide high quality bio-implant’s for patients with acute burns, traumatic injuries and chronic wounds. The Institute continually strives to be a leader in bio-implant research and discover new therapies to improve the lives of patients that have suffered a debilitating burn, traumatic injury or chronic non-healing wound. LifeNet Health is the world's largest provider of bio-implants and organs for transplantation whose mission is saving lives and restoring health by advancing the field of tissue engineering.
For additional information about SWAI and LifeNet Health, visit www.lifenethealth.org.
TheraGauze, a pre-moistened non-adherent polymer wound interface dressing, is manufactured in a certified clean room environment under strict quality protocols in Hampton, Virginia. Administrative offices are located in nearby Newport News, Virginia.
In peer reviewed, published clinical trials, TheraGauze has been shown to be highly effective in treating a wide variety of wounds, including diabetic foot ulcers, venous stasis ulcers, dehisced wounds, skin tears, pressure sores and burns. Additionally, TheraGauze is an excellent contact cover dressing for TheraSkin, autografts, bioengineered skin substitutes, and acellular, live skin collagen products because TheraGauze provides a moist nonadherent interface.
TheraGauze’s patented polymer Skin Moisture Rebalancing Technology (SMRT) gives TheraGauze its unique ability to regulate moisture differentially across a wound bed, and to aid in wound healing without maceration. TheraGauze will remain moist for multiple days, reducing the number of dressing changes necessary. TheraGauze can be removed without disturbing the wound bed, eliminating patient pain and avoiding interference with the healing process.
In addition to its non-stick properties, TheraGauze is a release platform for controlled delivery of aqueous based fluids. TheraGauze is compatible with a broad selection of antimicrobials. Available in two sizes, TheraGauze carries the American Podiatric Medical Association Seal of Approval.